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ABSTRACT
The ultimate goal of any genome-scale experiment
is to provide a functional interpretation of the data,
relating the available information with the hypoth-
eses that originated the experiment. Thus, func-
tional profiling methods have become essential
in diverse scenarios such as microarray experi-
ments, proteomics, etc. We present the FatiGO1,
a web-based tool for the functional profiling of
genome-scale experiments, specially oriented
to the interpretation of microarray experiments.
In addition to different functional annotations
(gene ontology, KEGG pathways, Interpro motifs,
Swissprot keywords and text-mining based bioen-
tities related to diseases and chemical compounds)
FatiGO1 includes, as a novelty, regulatory and
structural information. The regulatory information
used includes predictions of targets for distinct
regulatory elements (obtained from the Transfac
and CisRed databases). Additionally FatiGO1 uses
predictions of target motifs of miRNA to infer which
of these can be activated or deactivated in the
sample of genes studied. Finally, properties of gene
products related to their relative location and
connections in the interactome have also been
used. Also, enrichment of any of these functional
terms can be directly analysed on chromosomal
coordinates. FatiGO1 can be found at: http://
www.fatigoplus.org and within the Babelomics
environment http://www.babelomics.org
INTRODUCTION
It is well-known that genes do not operate alone within
the cell, but in an intricate network of interactions that we
only recently start to understand (1–3). These observa-
tions question the validity of the traditional reductionistic
vision, in which one or a few key genes would be the
causative factors of phenotypes or diseases (4), and urges
to take into consideration the functional dimension in the
interpretation of genome-scale experiments. In this new
scenario, the deregulation of blocks of functionally related
genes would be behind the disease phenotype (5). Thus,
there is a clear necessity for methods and tools to assist in
the functional interpretation of genome-scale experiments
such as microarrays, and to formulate genome-scale
hypothesis from a systems biology perspective (6–8) in a
way that the collective properties of groups of genes are
taken into account. Thus, a number of tools, pioneered by
Onto-Express (9), or FatiGO (10) that used multiple-
testing correction for the ﬁrst time, GOMiner (11), etc.,
can be considered representatives of a family of methods
that make use of diﬀerent functional annotations
(typically gene ontology (GO) or KEGG pathways) to
ﬁnd signiﬁcant functional enrichments that might be
useful in the interpretation of the results of microarray
experiments (8,12). Functional enrichment methods are
applied a posteriori on a group of genes of interest that
have been selected in a previous step on the basis of their
experimental values. For example, common criteria for
selecting groups of genes in the context of microarray
experiments would be their diﬀerential expression between
two classes of experiments. By means of this simple
two-step approach of gene selection followed by the
functional enrichment analysis, a reasonable biological
interpretation of a microarray experiment can be
achieved. Nevertheless, it has been noted that the artiﬁcial
imposition of a threshold in the gene selection step,
which ignores the cooperative behaviour among genes,
can have arbitrary consequences on the proper interpreta-
tion of the experiment (13). Thus, a new generation of
methods which directly test the coordinate behaviour
of blocks of functionally related genes has recently been
proposed (14,15).
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enrichment methods have a domain of application because
the groups of genes to study are deﬁned as discrete classes
without the necessity of applying any arbitrary threshold.
For example, many clustering methods deﬁne non-
overlapping groups (clusters) of genes in a deterministic
way. Other experiments such as ChIP-on-Chip can be used
to deﬁne groups of genes under the control of one or more
transcription factors, undergoing methylation, etc., and
such groups are also real discrete classes.
We present here the FatiGOþ, an advanced version
of the original FatiGO program (10). FatiGOþ is part
of a new generation of functional enrichment tools
characterized by the integration of heterogeneous, biologi-
cally relevant information. FatiGOþ includes new
functional annotations, more regulatory information,
structural data on protein interactions, new tests and
new facilities for the representation of the results, such as
displaying enrichment values onto pathway representa-
tions. Additional Table 1 shows a comparison between
FatiGOþ and other web-based tools for functional
enrichment analysis. New aspects such as the use of the
interactome scaﬀold (not merely the list of known
complexes as in other tools (16,17)), the use of new
regulatory information (e.g. miRNAs) or the use of
text-mining derived functional terms, just to cite the
most prominent features, represent a novelty of FatiGOþ
with respect to other tools.
Programcharacteristics and functionality
The original FatiGO program (10) was published in 2004
and, since then it has become a extensively used tool
(FatiGO/FatiGOþ have had an average of more than
100 experiments analysed per day and a cumulated total of
more than 37000 worldwide uses during the last year; see
a map with the geographical distribution of users here:
http://bioinfo.cipf.es/access_map/map.html). FatiGOþ
constitutes the extension of the concept of functional
enrichment not only to new functional annotations but
also to other relevant classes of biological concepts that
can be assigned to genes, or their corresponding gene
products, such as regulation and protein interaction data.
Purpose of the analysis. The main purpose of FatiGOþ is
to check for signiﬁcant enrichments of the functional
characteristics selected by the user in one of the lists of
genes with respect to the other one. Typically this
operation represents the comparison of a pre-selected list
of genes with respect to the genes of reference (usually the
rest of genes involved in the experiment). Functional
enrichment is carried out by many diﬀerent tools already
available (8), nevertheless, FatiGOþ can be used for other
purposes. The main screen displays four tabs. By default,
the enrichment analysis option is selected. There two lists
of genes (pre-selected and reference groups) can be input
for their comparison. Another tab oﬀer the possibility of
carrying out enrichment analysis using functional terms
deﬁned by the user. Additionally, other tab can be
used just for listing functional terms or characteristics
present in a list of genes. Finally, another tab presents
a diﬀerent interface, in which enrichment analysis can
be directly performed on chromosomal regions. Thus, the
pre-selected group of genes is deﬁned by delimiting the
coordinates of a chromosomal region and the reference
group is the rest of the genes in the genome. This is very
useful to study the functional impact of groups of genes
that cluster in close positions in the genome in pathologies
that occur with chromosomal copy number alterations.
Input data format. Input data format are simple text ﬁles
of genes (although data can also be pasted within the
corresponding boxes). The most common gene or protein
identiﬁers are accepted. This is achieved by using Ensembl
(version 42) identiﬁers as universal cross-references.
The following model organisms have been included in
FatiGOþ: Homo sapiens, Mus musculus, Gallus gallus,
Rattus norvegicus, Drosophila melanogaster, Danio
rerio, Caenorhabditis elegans, Saccharomyces cerevisiae,
Arabidopsis thaliana and Streptomyces coelicolor. Data
can also be directly imported from the GEPAS suite of
microarray data analysis (http://www.gepas.org). In this
way, it is possible from GEPAS to directly study
functional enrichment of genes contained in a cluster or
co-expression, genes diﬀerentially expressed, genes
selected in a predictor, genes contained in a given
chromosomal region, etc. When the option for functional
enrichment using user-deﬁned functional categories, in
addition to the lists of genes a table of correspondence
gene-annotation must be provided. Again this is a very
simple text ﬁle with two tab-delimited columns in which
the ﬁrst one contains gene identiﬁers and the second one
the functional annotation.
Understanding the differences between two lists of genes in
the light of functional annotations. We have included
in FatiGOþ diﬀerent functional annotations available
for genes. Probably the most widely used is GO (18).
GO represents the biological knowledge as a tree (more
precisely as a directed acyclic graph, DAG, in which a
node can have more that one parent) where elements near
the root of the tree make reference to more general
concepts while deeper elements near the leaves of the tree
make reference to more speciﬁc concepts. Conceptually we
can consider that, if a gene is annotated to a given level
then it is automatically annotated at all the upper levels
(all the parent levels) up to the root. Since genes are
annotated at diﬀerent levels of the GO hierarchy, it is
common to use this abstraction to choose a pre-deﬁned
level in the hierarchy instead of using directly the original
levels of annotation of the genes. This strategy is used to
produce GOSlim (see http://www.geneontology.org/
GO.slims.shtml), which are cut-down versions of the GO
hierarchy containing subsets of the terms in the whole GO
at diﬀerent levels. GoSlim levels give a broad overview of
the ontology content without the detail of the speciﬁc ﬁne
grained terms. Choosing a GOSlim level of GO increases
the power of the enrichment tests (7,8,12). What FatiGOþ
does is the enrichment analysis at diﬀerent GOSlim levels
and reports the deepest (the more detailed deﬁnition) level
at which signiﬁcance is found. This strategy is known as
nested inclusive analysis (NIA) (19).
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well-known source for functional annotation. We have
also included functional motifs mapped to proteins by the
Interpro database (21) and the keywords in the Swissprot
entries (22). All these functional annotations can be
considered discrete classes (that is, a gene has or has not
a given functional annotation) so, enrichment is tested by
means of Fisher’s exact test for 2 2 contingency tables
(10,23,24). For each functional annotation the genes
belonging to the two groups compared are distributed in
a2  2 contingency table, where rows account for
presence/absence of the annotation, and columns repre-
sent each of the two clusters.
Additionally, we have used text-mining methods (25) to
extract other functional aspects of the genes beyond the
ones covered by the ‘traditional’ repositories described
before. In the approach described here we have used two
types of speciﬁc words (bioentities): those referred to
chemical products and those related to diseases. The
bioentities were extracted from PubMed, and are related
to human genes by a score derived from the frequency of
gene-bioentity co-occurrences and depending on their
proximity within the text. The scores are based on how
unlikely it is to observe a certain level of co-occurrences
to happen by chance (26). The gene-bioentity corre-
spondence tables with the respective scores were
obtained using the AKS software (available at: http://
www.bioalma.com/aks2/). Contrarily to the case of GO
and other similar functional categories, bioentities are not
discrete classes. Thus, the membership of a gene to a
given bioentity is conditioned through the scores.
Then, instead of the usual Fisher’s (or equivalent) test,
we use a Kolmogorov–Smirnov test to check for bioentity
enrichments.
Finally, any other functional term can be used provid-
ing it can be represented as a table of correspondence
between genes and instances of the term. Any user-deﬁned
table of correspondence gene-term can be input by
FatiGOþ and functional enrichment with a Fisher’s
exact test on contingency tables can be conducted.
Understanding the differences between two lists of genes
using regulatory information. Information on the regula-
tion of gene expression can also be used within the context
of functional enrichment tests. It can be useful to
determine if, for example, a set of genes pre-selected
because they co-express across time are under the control
of the same transcription factor. Diﬀerent databases
containing transcription factor binding sites and other
regulatory motifs are available so as promoter regions of
the genes can be scanned for the possible presence of these
target motifs. We have used information on diverse
regulatory motifs from the CisRed (27) and Transfac
(28) databases. These motifs can be studied at diﬀerent
locations in the promoters (in the ﬁrst 1kb, in 5kb or up
to 10kb).
Also other levels of regulation beyond the transcription
factors or other common regulatory motifs can be
considered by including information on microRNAs
targets. It has recently been demonstrated the role of
miRNAs in the negative regulation of the expression of
their target genes (29). Actually, miRNAs have gained
importance as cancer markers as they have demonstrated
to be deregulated in some cancers (30). In the context of
gene expression one might be interested in knowing
whether there is some enrichment in miRNA target
sequences in genes that have been deregulated in a
particular cancer when compared to their non-deregulated
counterparts. A signiﬁcant enrichment would clearly point
to the presence or absence of one or several miRNAs.
Data on miRNA targets have been taken from the
miRBase (31).
Understanding the differences between two lists of genes
over the interactome scaffold. Data on protein–protein
interaction allows to understand the physical interplay
between blocks of genes. Two common cases of obvious
biological relevance, in which we can expect interactions
among genes, are protein complexes (or other protein
aggregates) and signalling cascades. For example, in the
context of gene expression it can be extremely useful
to study the eﬀect of gene expression changes within a
pre-deﬁned scaﬀold of interactions.
The parameter used here is the number of partners with
which a protein interacts. FatiGOþ will check, by means
of a Kolmogorov–Smirnov test for abnormally high
(signiﬁcant) number of interactions in one group of pre-
selected genes with respect to the reference group. That
would point to the possible existence of one or more
complexes (or at least to the existence of a complex
interaction scheme) within the group of pre-selected genes.
We use the modules graph and RBGL (32) from the
bioconductor package to manage the interactome and
calculate the parameters. The interactome database has
been built using the PIANA (33) program, that allows
integrating into one unique database diﬀerent sources of
protein–protein interactions. The databases included were:
BIND (34), DIP (35), HPRD (36), MIPS (37), as well as
interactions from diﬀerent publications (2,3,38).
Comparing a set of genes to lists of gene expression in
tissues and diseases. A quite common necessity in drug
discovery or when testing animal models is to know
whether the eﬀect of a drug is restoring the normal
function of a tissue or if a given model can be considered
to represent a given disease. A powerful method to check
the real impact of any treatment is to compare the
expression of the genes with the corresponding proﬁles of
gene expression in the situation aimed.
FatiGOþ uses two repositories containing information
of gene expression in diﬀerent tissues. One of them was
obtained from the SAGE Tag libraries (Cancer Genome
Anatomy Project). A total of 279 human libraries that
belong to 29 diﬀerent tissues and 190 mouse libraries from
26 tissues have been used (the data were obtained from:
http://cgap.nci.nih.gov/SAGE). The other repository con-
tains gene expression data obtained from microarray
experiments available from the Genomics Institute of the
Novartis Foundation data. A total of 79 human tissues
and 61 mouse tissues with normal histology were obtained
from http://wombat.gnf.org/index.html.
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all the diﬀerent functional annotations, regulatory ele-
ments, and the interactions according to the interactome
scaﬀold, are adjusted using the False Discovery Rate (39)
method. This produces a ﬁnal report in which the FDR-
adjusted p-values are provided for all the individual tests
conducted.
Representation of the results. Diﬀerent enrichment ana-
lysis are conducted through distinct tests and the results
are represented in a number of intuitive graphical
representations. The main results page contains a sum-
mary of all the tests performed. The user can follow the
links to ﬁnd details on each enrichment test conducted.
Figure 1 shows some of the graphical representation of
results that can be found for diﬀerent tests. For example,
Figure 1A shows the result of the NIA on the GO
hierarchy. Many GO levels have been analysed and the
deepest signiﬁcant terms are reported. The user can also
obtain the list of results at all the levels (Figure 1B). When
a graphical representation of the relationships among
genes exist, as is the case of KEGG pathways, these can be
represented to visualize the possible impact of the genes in
the structure. Figure 1C shows a pathway for which a
signiﬁcant enrichment was found, with the pre-selected
genes in red and the genes in the reference group in green.
The pathway images are obtained by using the public web
services from KEGG at http://soap.genome.jp/
KEGG.wsdl. When the biological information does not
deﬁne a discrete class we use a Kolmogorov–Smirnov test.
Figure 1D shows a diﬀerent graphical representation for
the result of one of such tests (in this case the number of
protein interaction partners).
CONCLUSIONS
Despite new strategies oriented to the study of diﬀerential
gene expression or other situations in which a threshold
must be imposed (8,14,15), there are still many scenarios
where discrete classes must be interpreted, in which the
functional enrichment analysis is required (e.g. functional
analysis of clustering results (40), ChIP-on-Chip experi-
ments, massive KOs, etc.)
Since functional enrichment analysis is a ‘classic’ among
the methods for the biological interpretation of lists of
genes there are numerous tools available for such purpose
(not all of them are web servers). Reviews can be found in
(8,12). A common criticism to many of these tools is that
A
B
C
D
Figure 1. Diﬀerent graphical representation of the results of the tests. (A) Deepest levels at which signiﬁcance was found in the GO hierarchy. (B) All
the GO annotations tested. Both, uncorrected and FDR-corrected P-values are shown. (C) A KEGG pathway with the genes in the pre-selected
group labelled in red and the genes in the reference group labelled in green. (D) The result of a test that compares the degree of protein interactions
in the pre-selected group of genes with respect to the reference group.
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slight diﬀerences in the tests or in the strategies for testing
(12). Programs for functional enrichment analysis must
improve their performances by expanding the biologically
relevant concepts to be tested beyond the common
functional annotations which, in some cases, implies the
implementation of diﬀerent types of tests. It is of special
importance the study of orthogonal concepts such as
function, regulation, physical interactions, etc., given that
it allows to detect genes with common annotations
(e.g. genes involved in a given pathway and under the
control of the same transcription factor), which provide
a more complete biological interpretation of the experi-
ment studied.
Given the number of distinct functional, regulatory,
structural and other biologically relevant concepts that
have been included in the FatiGOþ it can be considered
one of the most complete tools for studying functional
enrichment to our knowledge.
Since the biological interpretation of microarray experi-
ments represents a major demand of functional enrich-
ment methods we have connected FatiGOþ to our
GEPAS (41,42) suite for microarray data analysis.
Nevertheless, despite this primary use, it is important to
remark that FatiGOþ can be applied to any type of
genome-scale experiment (e.g. proteomics, massive KO
with siRNAs, whole genome genotyping, etc.) or even to
check genome-scale hypothesis (in evolution, population
genetics, development, etc.)
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